IM Cannabis Corp (IMCC)
NASDAQ:IMCC
IMCC Stock Chart & Stats
$1.44
-$0.13(-4.96%)
At close: 4:00 PM EST
$1.44
-$0.13(-4.96%)
Day’s Range― - ―
52-Week Range$0.30 - $7.12
Previous Close$2.49
Volume28.72K
Average Volume (3M)72.27K
Market Cap
$2.25M
Enterprise Value$32.03M
Total Cash (Recent Filing)$2.73M
Total Debt (Recent Filing)$16.27M
Price to Earnings (P/E)―
Beta1.39
Next Earnings
May 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.93
Shares Outstanding6,223,323
10 Day Avg. Volume74,089
30 Day Avg. Volume72,265
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-9.42
Price to Sales (P/S)0.15
P/FCF Ratio1.72
Enterprise Value/Market Cap14.26
Enterprise Value/Revenue0.59
Enterprise Value/Gross Profit3.31
Enterprise Value/Ebitda-4.61
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.32
Revenue Forecast (FY)$62.75M
Bulls Say, Bears Say
Bulls Say
Strong German Market Position & EU‑GMP PlatformGermany accounted for over two‑thirds of 2025 revenue with EU‑GMP certification and rapid sales growth. This regulatory certification and market scale create durable distribution advantages and higher barriers to entry versus smaller competitors.
Material Multi‑year Revenue ExpansionRevenue has expanded meaningfully over several years, reflecting successful market penetration and product adoption. A multi‑year growth trajectory supports operating scale, stronger supplier/customer bargaining, and potential margin improvement as fixed costs are leveraged.
2025 Operating & Free Cash Flow Turned PositiveThe swing to positive operating and free cash flow in 2025 materially improves near‑term liquidity and funds operations without immediate reliance on equity raises. If sustained, positive cash generation underpins reinvestment and reduces structural funding risk.
Bears Say
Negative Shareholders' Equity / Weakened Balance SheetNegative equity shrinks financial flexibility and makes leverage metrics effectively unstable. This structural weakness limits access to unsecured financing, raises creditor risk, and reduces the company's cushion against operational setbacks over the medium term.
Persistently Unprofitable Operating And Net MarginsDespite revenue gains, gross margins remain low (~16%–20%) and operating/net margins are negative, indicating underlying unit economics issues. Without sustained margin improvement, revenue growth alone may not produce durable profitability or self‑funding capability.
Reliance On Dilutive, Costly FinancingRecent convertible notes (interest, conversion floors, warrants) provide liquidity but create potential equity dilution and future share overhang. Structurally, repeated reliance on such financing raises cost of capital and can impair long‑term shareholder value and capital structure stability.
IM Cannabis Corp News
IMCC FAQ
What was IM Cannabis Corp’s price range in the past 12 months?
IM Cannabis Corp lowest stock price was $0.29 and its highest was $7.12 in the past 12 months.
What is IM Cannabis Corp’s market cap?
IM Cannabis Corp’s market cap is $2.25M.
When is IM Cannabis Corp’s upcoming earnings report date?
IM Cannabis Corp’s upcoming earnings report date is May 18, 2026 which is in 34 days.
How were IM Cannabis Corp’s earnings last quarter?
IM Cannabis Corp released its earnings results on Mar 30, 2026. The company reported -$0.929 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.929.
Is IM Cannabis Corp overvalued?
According to Wall Street analysts IM Cannabis Corp’s price is currently Overvalued.
Does IM Cannabis Corp pay dividends?
IM Cannabis Corp does not currently pay dividends.
What is IM Cannabis Corp’s EPS estimate?
IM Cannabis Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IM Cannabis Corp have?
IM Cannabis Corp has 6,223,323 shares outstanding.
What happened to IM Cannabis Corp’s price movement after its last earnings report?
IM Cannabis Corp reported an EPS of -$0.929 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.314%.
Which hedge fund is a major shareholder of IM Cannabis Corp?
Currently, no hedge funds are holding shares in IMCC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IM Cannabis Corp
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
Technical Analysis
Ownership Overview
54.57% Insiders
3.15% Other Institutional Investors
42.28% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---